These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8159859)

  • 21. The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke. Design, organization, and baseline results.
    Gent M; Blakely JA; Easton JD; Ellis DJ; Hachinski VC; Harbison JW; Panak E; Roberts RS; Sicurella J; Turpie AG
    Stroke; 1988 Oct; 19(10):1203-10. PubMed ID: 3051529
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A critical appraisal of ticlopidine, a new antiplatelet agent. Effectiveness and clinical indications for prophylaxis of atherosclerotic events.
    Haynes RB; Sandler RS; Larson EB; Pater JL; Yatsu FM
    Arch Intern Med; 1992 Jul; 152(7):1376-80. PubMed ID: 1627017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ticlopidine versus aspirin for the prevention of recurrent stroke. Analysis of patients with minor stroke from the Ticlopidine Aspirin Stroke Study.
    Harbison JW
    Stroke; 1992 Dec; 23(12):1723-7. PubMed ID: 1448821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Ticlopidine Aspirin Stroke Study].
    Lima JM
    Arq Bras Cardiol; 1990 Mar; 54(3):240. PubMed ID: 2288515
    [No Abstract]   [Full Text] [Related]  

  • 25. Antiplatelet treatment for prevention of cerebrovascular events in patients with vascular diseases: a systematic review and meta-analysis.
    Gouya G; Arrich J; Wolzt M; Huber K; Verheugt FW; Gurbel PA; Pirker-Kees A; Siller-Matula JM
    Stroke; 2014 Feb; 45(2):492-503. PubMed ID: 24368560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Strategies for preventing stroke.
    Kanter MC; Sherman DG
    Curr Opin Neurol Neurosurg; 1993 Feb; 6(1):60-5. PubMed ID: 8428068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prophylactic drug therapy in cerebrovascular disease.
    Unwin DH; Greenlee RG
    Am Fam Physician; 1993 Jul; 48(1):85-90. PubMed ID: 8322647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thrombotic thrombocytopenic purpura associated with ticlopidine in the setting of coronary artery stents and stroke prevention.
    Bennett CL; Davidson CJ; Raisch DW; Weinberg PD; Bennett RH; Feldman MD
    Arch Intern Med; 1999 Nov; 159(21):2524-8. PubMed ID: 10573042
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Myocardial infarct, stroke and vascular events reduced by a third].
    Z Kardiol; 1997 Nov; 86(11 Suppl Myokardinf):1-3. PubMed ID: 9437253
    [No Abstract]   [Full Text] [Related]  

  • 30. Ticlopidine induced cholestatic jaundice.
    Yim HB; Lieu PK; Choo PW
    Singapore Med J; 1997 Mar; 38(3):132-3. PubMed ID: 9269384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention of vascular events in patients with cerebrovascular disease: efficacy and appropriate duration of antiplatelet therapy.
    Habib GB
    Clin Cardiol; 2006 Jun; 29(6):244-8. PubMed ID: 16796073
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prevention and therapy of stroke].
    Nervenarzt; 1994 May; 65(5 Suppl):1-8. PubMed ID: 9131086
    [No Abstract]   [Full Text] [Related]  

  • 33. Prevention of stroke with ticlopidine: who benefits most? TASS Baseline and Angiographic Data Subgroup.
    Grotta JC; Norris JW; Kamm B
    Neurology; 1992 Jan; 42(1):111-5. PubMed ID: 1734290
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Secondary prevention of stroke and transient ischemic attack: is more platelet inhibition the answer?
    Liao JK
    Circulation; 2007 Mar; 115(12):1615-21. PubMed ID: 17389280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. What have we learned from recent antiplatelet trials?
    Easton JD
    Neurology; 1998 Sep; 51(3 Suppl 3):S36-8. PubMed ID: 9744831
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ticlopidine and antiplatelet therapy.
    Flores-Runk P; Raasch RH
    Ann Pharmacother; 1993 Sep; 27(9):1090-8. PubMed ID: 8219445
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ticlopidine: a new platelet aggregation inhibitor.
    Ito MK; Smith AR; Lee ML
    Clin Pharm; 1992 Jul; 11(7):603-17. PubMed ID: 1617911
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anticoagulants and antiplatelet agents in acute ischemic stroke.
    Pellegrino TR
    Va Med Q; 1998; 125(2):125-7. PubMed ID: 9577715
    [No Abstract]   [Full Text] [Related]  

  • 39. Rationale, design and baseline data of a randomized, double-blind, controlled trial comparing two antithrombotic regimens (a fixed-dose combination of extended-release dipyridamole plus ASA with clopidogrel) and telmisartan versus placebo in patients with strokes: the Prevention Regimen for Effectively Avoiding Second Strokes Trial (PRoFESS).
    Diener HC; Sacco R; Yusuf S; ;
    Cerebrovasc Dis; 2007; 23(5-6):368-80. PubMed ID: 17337887
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral antiplatelet therapy.
    Borja J
    JAMA; 2005 Feb; 293(7):793; author reply 794-5. PubMed ID: 15713764
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.